Vleresimi i proteines c reaktive me sensibilitet te larte ne semundjen koronare dhe lidhja e saj faktoret e tjere te riskut aterosklerotik

Autorët

  • Nevila Heta (Alliu)
  • Anyla Bulo
  • Etleva Refatllari
  • Irena Korita
  • Artan Godo
  • Albana Doko
  • Leonard Simoni
  • Indrit Temali

DOI:

https://doi.org/10.55312/op.v14i2.4735

Abstract

Proteina C-reaktive me sensibilitet të lartë është një proteinë e fazës akute e cila në ditët tona konsiderohet si një markues i rëndësishëm i inflamacionit ateroklerotik. Qëllimi ynë është vlerësimi i Hs-CRP si një markues i inflamacionit sistemik në procesin aterosklerotik dhe relacioni i Hs-CRP me ashpërsinë e lezioneve aterosklerotike të dedektuara me anë të angiografisë.

Keywords:

Proteine C reaktive me sensibilitet te larte,, ateroskleroze,, angiografi koronare, risk

Downloads

Download data is not yet available.

References

  1. Russell Ross, Atherosclerosis- An Inflamatory Disease. The New England Journal Of Medicine.340 (2) 115-126; 1999

  2. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particleenhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannosebinding protein in human serum. Ann Clin Biochem;35:745-753; 1998.

  3. Pepys MB. C-reactive protein fifty years on. Lancet;1:653-657; 1981.

  4. Zee RY, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis;162:217-219;2002.

  5. Peter Libby,Paul M. Ridker,Attilio Maseri. Inflammation and Atherosclerosis American Heart Association Circulation;105:1135-1143;2002.

  6. Johnson AM, Rohlfs E, Silverman LM. Proteins. Burtis CA Ashwood ER eds. Tietz textbook of clinical chemistry, 3rd ed:477-540;B Saunders Philadelphia. 1999.

  7. Ledue TB, Weiner DL, Sipe JD, Poulin SE, Collins MF, Rifai N. Analytical evaluation of particleenhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannosebinding protein in human serum. Ann Clin Biochem;35:745-753; 1998.

  8. Sakamoto M, Farrow G, Law T, Rifai N. Analytical evaluation of three second-generation highsensitivity CRP assays [Abstract]. Clin Chem;48:A31; 2002.

  9. High-Sensitivity C-Reactive Protein Potential Adjunct for Global Risk Assessment in the Primary Prevention of Cardiovascular Disease Paul M. Ridker, Circulation.;103:1813-1818;2001.

  10. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions Sarah de Ferranti, Nader Rifai. Clinica Chimica Acta 317;2002.

  11. Ford ES, Giles WH, Myers GL, Mannino DM. Population distribution of high-sensitivity C-reactive protein among US men: findings from National Health and Nutrition Examination Survey 1999–2000. Clin Chem;49:686-690; 2003.

  12. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a 13. statement for healthcare professionals from the Nutrition Committee, American Heart Association: ACC/AHA Scientific Advisory. Circulation.;99:178–182; 1999

  13. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and lowdensity lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med;347:1557-1565; 2002.

  14. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem;47:444-450; 2001.

  15. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J;20:954-959; 1999.

  16. Clearfield MB. C-Reactive Protein: A New Risk Assessment Tool for Cardiovascular DiseaseJ Am Osteopath Assoc, September 1,; 105(9): 409 – 416; 2005.

  17. Köenig W, Sund M, Fröhlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort

  18. Study, 1984 to 1992. Circulation;99:237-242; 1999

  19. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, III, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation;107:499-511; 2003

  20. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med;342:836-843; 2000.

  21. Gavin J. Blake, Paul M. Ridker Novel Clinical Markers of Vascular Wall Inflammation Circ Res.;89: 763-771;2001.

  22. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation;105:564-569; 2002.

  23. Ohsawa M, Okayama A, Nakamura M, Onoda T, Kato K, Itai K, Yoshida Y et al CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Preventive Medicine.Volume 41, Issue 2, 651–65; 2005.

  24. Stewart SH1, Mainous AG 3rd, Gilbert G.Relation between alcohol consumption and C-reactive protein levels in the adult US population. J Am Board Fam Pract. 15(6):437-42. 2002

  25. Herrington DM, Brosnihan KB, Pusser BE, Seely EW, Ridker PM, Rifai N, et al. Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. J Clin Endocrinol Metab;86:4216-4222; 2001.

  26. Robert Blackburn, Philippe Giral, Eric Bruckert, Elevated C-Reactive Protein Constitutes an Independent Predictor of Advanced Carotid Plaques in Dyslipidemic Subjects. Arterioscler

  27. Thromb Vasc Biol;21:1962-1968;2001.

  28. P. W. F. Wilson, B.-H. Nam, M. Pencina, R. B. D’Agostino Sr, E. J. Benjamin, and C. J. O’Donnell.CReactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study Archives of Internal Medicine, November 28, ; 165(21): 2473 – 2478; 2005.

Downloads

Published

2024-06-06

How to Cite

Heta , N., Bulo, A., Refatllari, E., Korita, I., Godo, A., Doko, A., … Temali, I. (2024). Vleresimi i proteines c reaktive me sensibilitet te larte ne semundjen koronare dhe lidhja e saj faktoret e tjere te riskut aterosklerotik. Optime, 14(2), 63–73. https://doi.org/10.55312/op.v14i2.4735

Numër

No. 2 (2022): Optime

Section

Artikuj